SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Aerie Pharmaceuticals Inc. – ‘8-K’ for 8/22/22

On:  Tuesday, 8/23/22, at 5:13pm ET   ·   For:  8/22/22   ·   Accession #:  1193125-22-227609   ·   File #:  1-36152

Previous ‘8-K’:  ‘8-K’ on 8/23/22 for 8/22/22   ·   Next:  ‘8-K’ on / for 9/13/22   ·   Latest:  ‘8-K’ on / for 11/21/22   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/23/22  Aerie Pharmaceuticals Inc.        8-K:1,9     8/22/22   11:757K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     52K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    467K 
                Liquidation or Succession                                        
 6: R1          Document and Entity Information                     HTML     47K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- d634562d8k_htm                      XML     14K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- aeri-20220822_lab                     XML     55K 
 5: EX-101.PRE  XBRL Presentations -- aeri-20220822_pre              XML     35K 
 3: EX-101.SCH  XBRL Schema -- aeri-20220822                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
11: ZIP         XBRL Zipped Folder -- 0001193125-22-227609-xbrl      Zip    136K 




        
Filing Submission 0001193125-22-227609 – SGML Text

Original SGML Text submitted by:  Donnelley Financial Solutions/FA  (as Filing Agent) 

Show all <DOCUMENT> <TEXT> elements below – 757K                        Top    Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20220823-171428	 Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20220823-171409	 Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20220823-171335	 Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001193125-22-227609
<TYPE>				8-K
<PUBLIC-DOCUMENT-COUNT>		13
<PERIOD>			20220822
<ITEMS>				1.01
<ITEMS>				9.01
<FILING-DATE>			20220823
<DATE-OF-FILING-DATE-CHANGE>	20220823
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		AERIE PHARMACEUTICALS INC
<CIK>				0001337553
<ASSIGNED-SIC>			2836
<IRS-NUMBER>			203109565  20-3109565
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			8-K
<ACT>				34
<FILE-NUMBER>			001-36152
<FILM-NUMBER>			221188277
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			4301 EMPEROR BOULEVARD
<STREET2>			SUITE 400
<CITY>				DURHAM
<STATE>				NC
<ZIP>				27703
<PHONE>				(919) 237-5300
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			4301 EMPEROR BOULEVARD
<STREET2>			SUITE 400
<CITY>				DURHAM
<STATE>				NC
<ZIP>				27703
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>		8-K
<SEQUENCE>	1
<FILENAME>	d634562d8k.htm
<DESCRIPTION>	8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:aeri="http://www.aeriepharma.com/20220822" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
       Show <XBRL>: 219 lines (widest: 5,164 characters) - 52K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-2.1
<SEQUENCE>	2
<FILENAME>	d634562dex21.htm
<DESCRIPTION>	EX-2.1
<TEXT>
<HTML>
       Show <HTML>: 3,347 lines (widest: 251 characters) - 467K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-101.SCH
<SEQUENCE>	3
<FILENAME>	aeri-20220822.xsd
<DESCRIPTION>	XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
       Show <XBRL>: 41 lines (widest: 251 characters) - 3K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-101.LAB
<SEQUENCE>	4
<FILENAME>	aeri-20220822_lab.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
       Show <XBRL>: 111 lines (widest: 219 characters) - 18K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-101.PRE
<SEQUENCE>	5
<FILENAME>	aeri-20220822_pre.xml
<DESCRIPTION>	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
       Show <XBRL>: 64 lines (widest: 290 characters) - 12K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	6
<FILENAME>	R1.htm
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<html>
       Show <HTML>: 838 lines (widest: 387 characters) - 39K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	7
<FILENAME>	d634562d8k_htm.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
       Show <XML>: 46 lines (widest: 136 characters) - 4K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EXCEL
<SEQUENCE>	8
<FILENAME>	Financial_Report.xlsx
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 131 lines (Unix-to-Unix encoding) - 8K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	9  Not a Document/Exhibit
<FILENAME>	Show.js
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 5 lines (widest: 296 characters) - 973 bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	10  Not a Document/Exhibit
<FILENAME>	report.css
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 182 lines (widest: 57 characters) - 4K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		XML
<SEQUENCE>	11  Document/Exhibit 9
<FILENAME>	FilingSummary.xml
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
       Show <XML>: 52 lines (widest: 192 characters) - 2K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		JSON
<SEQUENCE>	14  12  Document/Exhibit 10
<FILENAME>	MetaLinks.json
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 609 lines (widest: 316 characters) - 18K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		ZIP
<SEQUENCE>	15  13  Document/Exhibit 11
<FILENAME>	0001193125-22-227609-xbrl.zip
<DESCRIPTION>	IDEA: XBRL DOCUMENT
<TEXT>
       Show <TEXT>: 2,237 lines (Unix-to-Unix encoding) - 136K bytes  
</TEXT>
</DOCUMENT>
</SUBMISSION>
Top

Filing Submission 0001193125-22-227609   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 12:47:03.2pm ET